StockData

TFA Therapeutics, Inc. (RAJAF) stock

RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on May 15, 2026Score 7/30
$9.18+0.00 (0.00%)

Close on Oct 16, 2026Market cap –P/E –Yield –

What TFA Therapeutics keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Gross margin61.1%vs 52.8%
Operating margin-11.3%vs -42.9%
EBITDA margin-11.3%vs -29.3%
Pretax margin-12.4%vs -13.0%
Net margin-12.4%vs -39.9%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on assets-3.34%vs -40.7%

How hard the assets work

Revenue per dollar of assets0.27vs 0.39
Inventory turns a year0.72vs 2.68
Revenue per employee$77.83Kvs $405.05K
Profit per employee-$9.68Kvs -$704.12K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by $3.20K.

Cash and short-term investments$3.20K
EBITDA, trailing twelve months-$141.13K

Leverage and liquidity

Current ratio0.19vs 3.28
Quick ratio0.00vs 2.37

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

5 of 9 tests passed

How the shares have traded

Total return includes reinvested dividends, to the close on Oct 16, 2026

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

RAJAFS&P 500
PeriodRAJAFS&P 500DifferenceRAJAF per yearS&P 500 per year
1 month0.0%+1.5%−1.5 pts
3 months0.0%+1.9%−1.9 pts
Year to date0.0%+12.8%−12.8 pts
1 year0.0%+16.8%−16.8 pts

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 31, 2025.

0M RAJAF shares were sold short on Oct 31, 2025. At recent volumes it would take 1.8 days to buy them back.

Shares sold shortDays to cover

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 31, 202561–341.8
Nov 15, 20243–4341.0
Oct 15, 20241,000–1,0911.0

Every measure, in full

35 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Dec 31, 2025
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
0.00%
11.0%
Float
111M
49M
Shares Held by Insiders
0.00%
11.3%

MarginsIndustry

Gross Margin
61.1%
52.8%
Operating Margin
-11.3%
-42.9%
Pretax Margin
-12.4%
-13.0%
Profit Margin
-12.4%
-39.9%
EBITDA Margin
-11.3%
-29.3%

Returns on capitalIndustry

Return on Assets (ROA)
-3.34%
-40.7%

Financial positionIndustry

Current Ratio
0.19
3.28
Quick Ratio
0.00
2.37

GrowthIndustry

Revenue Growth (YoY)
-0.65%
5.68%
Revenue Growth (3Y CAGR)
185.9%
2.25%

EfficiencyIndustry

Asset Turnover
0.27
0.39
Inventory Turnover
0.72
2.68
Revenue Per Employee
$77.83K
$405.05K
Profits Per Employee
-$9.68K
-$704.12K
Employee Count
16
75

Income statement (TTM)Industry

Revenue
$1.25M
$58.79M
Gross Profit
$760.74K
$103.58M
Operating Income
-$141.13K
-$21.49M
Pretax Income
-$154.82K
-$14.83M
Net Income
-$154.82K
-$22.47M
EBITDA
-$141.13K
-$17.14M
EPS (Diluted)
$0.00
-$0.83

Balance sheetIndustry

Net Cash (Debt)
$3.20K
$15.31M
Net Cash Per Share
$0.00
$0.72
Equity (Book Value)
-$534.55K
$49.40M
Book Value Per Share
-$0.00
$1.45
Tangible Book Value
-$534.55K
$23.58M
Working Capital
-$4.19M
$74.34M

Cash flow (TTM)Industry

Operating Cash Flow
-$35.85K
-$12.17M

Scores and fair valueIndustry

Piotroski F-Score
5
4

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?